Early dilation of the infarcted segment in acute transmural myocardial infarction: role of infarct expansion in acute left ventricular enlargement
JA Erlebacher,
JL Weiss,
ML Weisfeldt,
and
BH Bulkley
Left ventricular enlargement after myocardial infarction is a poor prognostic sign, the mechanism of which has not been well defined. Early left ventricular dilation may be due to the Frank-Starling effect, which results in an increase in the length of uninfarcted segments in response to a reduction in contractile muscle mass. In contrast to this adaptive physiologic mechanism, left ventricular dilation may alternatively be caused by a pathologic process that stretches and thins the infarcted myocardial segment (that is, infarct expansion). To determine the relative contributions of these two mechanisms to left ventricular dilation after an initial transmural anterior myocardial infarction, two-dimensional echocardiograms were obtained from 27 patients within 72 hours of the onset of symptoms of myocardial infarction and from 13 healthy control subjects. In the minor-axis echocardiographic view at the level of the papillary muscles, anterior and posterior endocardial segment lengths at end-diastole were measured with a microprocessor-based graphic system. The papillary muscles were used as internal landmarks to demarcate the anterior and posterior segments. Anterior (infarcted) segment length in patients with myocardial infarction was 11.6 +/- 2.2 cm (mean +/- SD), whereas in control subjects, anterior segment length was 8.6 +/- 1.2 cm (p less than 0.001). Posterior (uninfarcted) segment length in the patients was not significantly different from posterior segment length in the control subjects (5.4 +/- 1.2 versus 5.3 +/- 1.0 cm, respectively). Measurable left ventricular dilation during the first 3 days after transmural anterior myocardial infarction is due to dilation of the infarcted segment and not of the normal uninfarcted segment.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:

|
 |

|
 |
 
M. Morita, C. E. Eckert, K. Matsuzaki, M. Noma, L. P. Ryan, J. A. Burdick, B. M. Jackson, J. H. Gorman III, M. S. Sacks, and R. C. Gorman
Modification of Infarct Material Properties Limits Adverse Ventricular Remodeling
Ann. Thorac. Surg.,
August 1, 2011;
92(2):
617 - 624.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. G. Masci, J. Ganame, M. Francone, W. Desmet, V. Lorenzoni, I. Iacucci, A. Barison, I. Carbone, M. Lombardi, L. Agati, et al.
Relationship between location and size of myocardial infarction and their reciprocal influences on post-infarction left ventricular remodelling
Eur. Heart J.,
July 1, 2011;
32(13):
1640 - 1648.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Ifkovits, E. Tous, M. Minakawa, M. Morita, J. D. Robb, K. J. Koomalsingh, J. H. Gorman III, R. C. Gorman, and J. A. Burdick
Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model
PNAS,
June 22, 2010;
107(25):
11507 - 11512.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chua, L.-T. Chang, C.-K. Sun, J.-J. Sheu, F.-Y. Lee, A. A. Youssef, C.-H. Yang, C.-J. Wu, and H.-K. Yip
Time Courses of Subcellular Signal Transduction and Cellular Apoptosis in Remote Viable Myocardium of Rat Left Ventricles Following Acute Myocardial Infarction: Role of Pharmacomodulation
Journal of Cardiovascular Pharmacology and Therapeutics,
June 1, 2009;
14(2):
104 - 115.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. P. Ryan, K. Matsuzaki, M. Noma, B. M. Jackson, T. J. Eperjesi, T. J. Plappert, M. G. St. John-Sutton, J. H. Gorman III, and R. C. Gorman
Dermal Filler Injection: A Novel Approach for Limiting Infarct Expansion
Ann. Thorac. Surg.,
January 1, 2009;
87(1):
148 - 155.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Blom, J. J. Pilla, J. Arkles, L. Dougherty, L. P. Ryan, J. H. Gorman III, M. A. Acker, and R. C. Gorman
Ventricular Restraint Prevents Infarct Expansion and Improves Borderzone Function After Myocardial Infarction: A Study Using Magnetic Resonance Imaging, Three-Dimensional Surface Modeling, and Myocardial Tagging
Ann. Thorac. Surg.,
December 1, 2007;
84(6):
2004 - 2010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. G. Spinale
Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function
Physiol Rev,
October 1, 2007;
87(4):
1285 - 1342.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. St John Sutton, D. Lee, J. L. Rouleau, S. Goldman, T. Plappert, E. Braunwald, and M. A. Pfeffer
Left Ventricular Remodeling and Ventricular Arrhythmias After Myocardial Infarction
Circulation,
May 27, 2003;
107(20):
2577 - 2582.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P Garot, O Pascal, M Simon, J L Monin, E Teiger, J Garot, P Gueret, and J L Dubois-Rande
Impact of microvascular integrity and local viability on left ventricular remodelling after reperfused acute myocardial infarction
Heart,
April 1, 2003;
89(4):
393 - 397.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Etoh, C. Joffs, A. M. Deschamps, J. Davis, K. Dowdy, J. Hendrick, S. Baicu, R. Mukherjee, M. Manhaini, and F. G. Spinale
Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pigs
Am J Physiol Heart Circ Physiol,
September 1, 2001;
281(3):
H987 - H994.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. St. J. Sutton and N. Sharpe
Left Ventricular Remodeling After Myocardial Infarction : Pathophysiology and Therapy
Circulation,
June 27, 2000;
101(25):
2981 - 2988.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Ito, Y. Taniyama, K. Iwakura, N. Nishikawa, T. Masuyama, T. Kuzuya, M. Hori, Y. Higashino, K. Fujii, and T. Minamino
Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction
J. Am. Coll. Cardiol.,
March 1, 1999;
33(3):
654 - 660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Mahmarian, L. A. Moye, D. A. Chinoy, R. F. Sequeira, G. B. Habib, W. J. Henry, A. Jain, B. R. Chaitman, C. S. W. Weng, H. Morales-Ballejo, et al.
Transdermal Nitroglycerin Patch Therapy Improves Left Ventricular Function and Prevents Remodeling After Acute Myocardial Infarction : Results of a Multicenter Prospective Randomized, Double-Blind, Placebo-Controlled Trial
Circulation,
May 26, 1998;
97(20):
2017 - 2024.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. St. J. Sutton, M. A. Pfeffer, L. Moye, T. Plappert, J. L. Rouleau, G. Lamas, J. Rouleau, J. O. Parker, M. O. Arnold, B. Sussex, et al.
Cardiovascular Death and Left Ventricular Remodeling Two Years After Myocardial Infarction : Baseline Predictors and Impact of Long-term Use of Captopril: Information From the Survival and Ventricular Enlargement (SAVE) Trial
Circulation,
November 18, 1997;
96(10):
3294 - 3299.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. D. Cheitlin, J. S. Alpert, W. F. Armstrong, G. P. Aurigemma, G. A. Beller, F. Z. Bierman, T. W. Davidson, J. L. Davis, P. S. Douglas, L. D. Gillam, et al.
ACC/AHA Guidelines for the Clinical Application of Echocardiography : A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography) Developed in Collaboration With the American Society of Echocardiography
Circulation,
March 18, 1997;
95(6):
1686 - 1744.
[Full Text]
|
 |
|

|
 |

|
 |
 
F. Nijland, O. Kamp, F. W.A. Verheugt, G. Veen, and C. A. Visser
Long-term Implications of Reocclusion on Left Ventricular Size and Function After Successful Thrombolysis for First Anterior Myocardial Infarction
Circulation,
January 7, 1997;
95(1):
111 - 117.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. Ito, A. Maruyama, K. Iwakura, S. Takiuchi, T. Masuyama, M. Hori, Y. Higashino, K. Fujii, and T. Minamino
Clinical Implications of the `No Reflow' Phenomenon : A Predictor of Complications and Left Ventricular Remodeling inReperfused Anterior Wall Myocardial Infarction
Circulation,
January 15, 1996;
93(2):
223 - 228.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Sigurdsson and K. Swedberg
Prevention of Congestive Heart Failure by ACE Inhibition in Patients with Acute Myocardial Infarction
European Journal of Cardiovascular Prevention & Rehabilitation,
October 1, 1995;
2(5):
406 - 412.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Cody
Comparing Angiotensin-Converting Enzyme Inhibitor Trial Results in Patients With Acute Myocardial Infarction
Arch Intern Med,
September 26, 1994;
154(18):
2029 - 2036.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Groden
Vasodilator Therapy for Congestive Heart Failure: Lessons From Mortality Trials
Arch Intern Med,
February 22, 1993;
153(4):
445 - 454.
[Abstract]
[PDF]
|
 |
|
|